The natural gas industry in India, which long ago finished its initial investment phase and reached a plateau, is entering another capex cycle as the availability of gas continues to grow, while demand remains unfulfilled. No doubt the industry’s present stable growth rates are set to witness a...

I have recently come across an interesting article in ET, that claims that the Pharma companies that are making Generic Drugs and have a global foot-print esp in USA markets, are going to grab a great opportunity that comes in the form of expiry of patent worth a market share of $100-140 billion and...

Suggested by: Mehraboon Irani of Centrum Broking Source: http://www.moneycontrol.com After Ramesh Sobti and team of senior executives from ABN AMRO took over, there has been a sea change as far as the performance of IndusInd Bank goes. The net NPA coming down to 0.6% and should fall down further, RoE...

Adviced By: Mehraboon Irani of Centrum Broking Source: http://www.moneycontrol.com The only problem, which Arshiya International faces, is strain on its balance sheet. The company has got lot of capex plans. They have so far handled the financials pretty well but there is going to be strain on the balance...

Advised By: Mehraboon Iraniof Centrum Broking Source: http://www.moneycontrol.com Most pharmaceutical stocks have gone up a little bit too sharply with what happened in the US. But the fact is some of them have gone up sharply for reasons, which are right and some of them have gone up sharply for no...

In an interview with CNBC-TV18, Sudarshan Sukhani of Technical Trends and Shahina Mukadam, Director, Varun Capital Markets, discuss various stocks, which were buzzing last week and advice how to trade them in the week ahead. On Infosys Technologies: Sudarshan Sukhani, Technical Trends is of the view...